Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-08

Clinical Trial Update: Tear Cytokine Analysis as a Prediction or Diagnostic Marker in Ocular GvHD

View source ↗

Summary

The trial evaluated tear cytokines as a potential predictor or diagnostic marker for ocular graft-versus-host disease, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yonsei University | Conditions: Chronic Graft-versus-host Disease | Status: COMPLETED